Kamal Tolba

Suggest Changes
Learn More
BACKGROUND E2303 evaluated cetuximab, paclitaxel, and carboplatin used as induction therapy and concomitant with radiation therapy in patients with stage III/IV head and neck squamous cell carcinoma(More)